Brief Report: Randomized, Double-Blind Comparison of Tenofovir Alafenamide (TAF) vs Tenofovir Disoproxil Fumarate (TDF), Each Coformulated With Elvitegravir, Cobicistat, and Emtricitabine (E/C/F) for Initial HIV-1 Treatment: Week 144 Results-Reference-Cited by-同舟云学术

Brief Report: Randomized, Double-Blind Comparison of Tenofovir Alafenamide (TAF) vs Tenofovir Disoproxil Fumarate (TDF), Each Coformulated With Elvitegravir, Cobicistat, and Emtricitabine (E/C/F) for Initial HIV-1 Treatment: Week 144 Results

Published:2017-06-01 Issue:2 Volume:75 Page:211-218
ISSN:1525-4135
Container-title:JAIDS Journal of Acquired Immune Deficiency Syndromes
language:en
Short-container-title:

Author:

Arribas José R.,Thompson Melanie,Sax Paul E.,Haas Bernhard,McDonald Cheryl,Wohl David A.,DeJesus Edwin,Clarke Amanda E.,Guo Susan,Wang Hui,Callebaut Christian,Plummer Andrew,Cheng Andrew,Das Moupali,McCallister Scott

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Infectious Diseases

Reference20 articles.

1. Chronic administration of tenofovir to rhesus macaques from infancy through adulthood and pregnancy: summary of pharmacokinetics and biological and virological effects;Van Rompay;Antimicrob Agents Chemother.,2008

2. Tenofovir use is associated with a reduction in calculated glomerular filtration rates in the Swiss HIV Cohort Study;Fux;Antivir Ther.,2007

3. Greater tenofovir-associated renal function decline with protease inhibitor-based versus nonnucleoside reverse-transcriptase inhibitor-based therapy;Goicoechea;J Infect Dis.,2008

4. The effect of lopinavir/ritonavir on the renal clearance of tenofovir in HIV-infected patients;Kiser;Clin Pharmacol Ther.,2008

5. Tenofovir-associated kidney toxicity in HIV-infected patients: a review of the evidence;Hall;Am J Kidney Dis.,2011

Cited by 101 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative Metabolic Effects of Integrase Inhibitor and Emtricitabine-Containing Tenofovir Derivatives in People Living with HIV: A Multi-Center Retrospective Analysis;2024-08-09

2. Inflammation in HIV and Its Impact on Atherosclerotic Cardiovascular Disease;Circulation Research;2024-05-24

3. Pharmacokinetics and safety of coformulated bictegravir, emtricitabine, and tenofovir alafenamide in children aged 2 years and older with virologically suppressed HIV: a phase 2/3, open-label, single-arm study;The Lancet HIV;2024-05

4. Renal safety of tenofovir alafenamide-based antiretroviral therapy in people with HIV: A mini-review;BioScience Trends;2024-04-30

5. Antiretrovirals and Weight Change: Weighing the Evidence;Clinical Infectious Diseases;2024-04-12